Cargando…
CDK6 Is a Potential Prognostic Biomarker in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a threatening hematological malignant disease in which new successful approaches in therapy are needed. Cyclin-dependent kinase 6 (CDK6), a regulatory enzyme of the cell cycle that plays an important role in leukemogenesis and the maintenance of leukemia stem cells (L...
Autores principales: | Liu, Wei, Yi, Jin-Mou, Liu, Yi, Chen, Cong, Zhang, Kai-Xuan, Zhou, Cheng, Zhan, Hui-En, Zhao, Liang, Morales, Stephanie, Zhao, Xie-Lan, Zeng, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882723/ https://www.ncbi.nlm.nih.gov/pubmed/33597968 http://dx.doi.org/10.3389/fgene.2020.600227 |
Ejemplares similares
-
SLC25A1-associated prognostic signature predicts poor survival in acute myeloid leukemia patients
por: Liu, Fangshu, et al.
Publicado: (2023) -
The Prognostic Value and Function of HOXB5 in Acute Myeloid Leukemia
por: Chen, Miao, et al.
Publicado: (2021) -
A Prognostic Autophagy-Related Long Non-coding RNA (ARlncRNA) Signature in Acute Myeloid Leukemia (AML)
por: Zhao, Chunxia, et al.
Publicado: (2021) -
Identification and Validation of STAT6 as a Prognostic and Predictive Biomarker in Acute Myeloid Leukemia
por: Liu, Wei, et al.
Publicado: (2020) -
Novel Gene Signature Reveals Prognostic Model in Acute Myeloid Leukemia
por: Qu, Ying, et al.
Publicado: (2020)